...
首页> 外文期刊>Biochemistry (Moscow). Supplement, Series B. Biomedical chemistry >The Study of Complex Formation of Human Recombinant HSP70 with Tumor-Associated Peptides
【24h】

The Study of Complex Formation of Human Recombinant HSP70 with Tumor-Associated Peptides

机译:人重组HSP70与肿瘤相关肽复合物形成的研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Molecular chaperones of the HSP70 family (70 kDa heat shock proteins) are involved in presentation of exogenous antigenic peptides by antigen-presenting cells (APC). HSP70 complexes with tumor-associated peptides are powerful immunotherapeutic agents, inducing an adaptive cytotoxic T-cell mediated immune response. Several clinical trials have shown that HSP-based autological anticancer vaccines possess high efficiency and safety. However, sometimes it is impossible to isolate sufficient amount of such vaccines and so human recombinant HSP are used for in vitro loading with tumor-associated peptides. In this study we have investigated binding of two human recombinant proteins HSP70_(HYB) and HSC70 with antigenic peptides of different origin and optimized conditions for complex formation. The proposed method for complex formation increases the repertoire of HSP70 bound peptides compared with in vivo formed complexes.
机译:HSP70家族的分子伴侣(70 kDa热激蛋白)参与抗原呈递细胞(APC)呈递外源抗原肽。 HSP70与肿瘤相关肽的复合物是强大的免疫治疗剂,可诱导适应性细胞毒性T细胞介导的免疫反应。多项临床试验表明,基于HSP的自体抗癌疫苗具有高效和安全性。但是,有时不可能分离出足够数量的此类疫苗,因此将人重组HSP用于体外载有肿瘤相关肽。在这项研究中,我们研究了两种人类重组蛋白HSP70_(HYB)和HSC70与不同来源的抗原肽和复合物形成的优化条件的结合。与体内形成的复合物相比,提出的复合物形成方法增加了HSP70结合的肽库。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号